Cortes, Jorge http://orcid.org/0000-0002-8636-1071
Lang, Fabian
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 6 January 2021
Accepted: 1 March 2021
First Online: 18 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: The authors received nonfinancial support (assistance with manuscript preparation) from Nucleus Global, which received funding from Novartis Pharmaceuticals Corporation. JC served as a consultant for Novartis, Pfizer, and Takeda and received research funds from Novartis, Pfizer, Takeda, and Sun Pharma. FL served as a consultant for Novartis, Bristol Myers Squibb, Celgene, and Incyte; received research funds from Novartis; and received honoraria from Novartis, Bristol Myers Squibb, Celgene, and Incyte.